Pfizer describes absorption of Wyeth ops; NanoSonic to make pulse-dried APIs;

> A Pfizer senior VP describes the big pharma's initiative to integrate manufacturing and outsourcing activities in the wake of the Wyeth acquisition. 12-minute Podcast

> CTD Holdings has launched NanoSonic Products, a subsidiary with the goal of using pulse dryer technology to produce c-GMP dry APIs by end of year. Release

> Canadian regulators have given Dynavax the go-ahead to start testing the lot-to-lot consistency of commercial vaccine and to complete the safety database for the HEPLISAV hepatitis B vaccine candidate. Announcement

> Quebec-based vaccine developer Medicago, which uses virus-like particle and proprietary manufacturing technologies, will present at this week's 6th WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials. Release

> Linguamatics, a U.K.-based text-mining platform provider for life sciences enterprises, has opened a U.S. facility in Newton, MA, just outside Boston. Release


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.